Table 6.
Tube Group | Trabeculectomy Group | P-value | |
---|---|---|---|
ETDRS VA, mean ± SD | |||
Baseline | 73 ± 20 | 73 ± 20 | 0.96‡ |
5 years | 69 ± 23 | 66 ± 27 | 0.50‡ |
Change* | −6 ± 17 | −11 ± 21 | 0.13‡ |
| |||
Snellen VA, logMAR mean ± SD | |||
Baseline | 0.20 ± 0.42 | 0.25 ± 0.51 | 0.42‡ |
5 years | 0.30 ± 0.54 | 0.42 ± 0.81 | 0.24‡ |
Change* | 0.16 ± 0.37 | 0.21 ± 0.52 | 0.43‡ |
| |||
Loss of ≥ 2 Snellen lines, n (%)† | 31 (32) | 29 (31) | 1.00§ |
Glaucoma | 9 | 9 | |
Cataract | 8 | 8 | |
Macular disease | 5 | 4 | |
Other | 2 | 5 | |
Unknown | 9 | 3 |
ETDRS = Early Treatment Diabetic Retinopathy Study; SD = standard deviation; VA = visual acuity
Not all patients seen at baseline returned for 5-year visits, so the baseline mean minus the 5-year mean does not equal the change
Some patients had more than 1 reason for decreased vision
Student t-test
Chi-square test